ARCHIVES

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 16 No. 06 | February 9, 1990

Download PDF Visit The Full Archive

Related Articles

Small Businesses Receive $18 Million From NCI Through SBIR Program

July 31, 1992

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

September 3, 2010

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

September 9, 1977

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility

February 1, 1980